References:
  1. Corrado D, Basso C. Arrhythmogenic left ventricular cardiomyopathy.Heart. 2022 May;108(9):733-743. doi: 10.1136/heartjnl-2020-316944. Epub 2021 Jul 13.
  2. Vimalanathan AK, Ehler E, Gehmlich K. Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy. Biophys Rev . 2018;10(4):973-982. doi:10.1007/s12551-018-0437-0
  3. Costa S, Koch K, Gasperetti A, et al. Changes in Exercise Capacity and Ventricular Function in Arrhythmogenic Right Ventricular Cardiomyopathy: The Impact of Sports Restriction during Follow-Up. J Clin Med . 2022;11(5):1150. Published 2022 Feb 22. doi:10.3390/jcm11051150
  4. Berte B, Denis A, Amraoui S, et al. Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy.Circ Arrhythm Electrophysiol . 2015 Dec;8(6):1403-12. doi: 10.1161/CIRCEP.115.003213. Epub 2015 Aug 26.
  5. Azaouagh A, Churzidse S, Konorza T, Erbel R. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update. Clin Res Cardiol . 2011;100(5):383-394. doi:10.1007/s00392-011-0295-2
  6. Vahidnezhad H, Youssefian L, Faghankhani M, et al. Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility. Sci Rep . 2020;10(1):21622. Published 2020 Dec 10. doi:10.1038/s41598-020-78344-9
  7. Akdis D, Saguner AM, Shah K, et al. Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome. Eur Heart J . 2017;38(19):1498-1508. doi:10.1093/eurheartj/ehx011
  8. Corrado D, van Tintelen PJ, McKenna WJ, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J . 2020;41(14):1414-1429. doi:10.1093/eurheartj/ehz669
  9. Miles C, Finocchiaro G, Papadakis M, et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy. Circulation . 2019;139(15):1786-1797. doi:10.1161/CIRCULATIONAHA.118.037230
  10. Cipriani A, Bauce B, De Lazzari M, et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis with Dilated Cardiomyopathy. J Am Heart Assoc . 2020;9(5):e014628. doi:10.1161/JAHA.119.014628
  11. Campuzano O, Alcalde M, Iglesias A, et al. Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation. J Clin Pathol . 2012;65(12):1077-1083. doi:10.1136/jclinpath-2012-201022
  12. Li D, Liu Y, Maruyama M, et al. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Hum Mol Genet . 2011;20(23):4582-4596. doi:10.1093/hmg/ddr392
  13. Alcalde M, Campuzano O, Sarquella-Brugada G, et al. Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy. Clin Res Cardiol . 2015;104(4):288-303. doi:10.1007/s00392-014-0794-z
  14. Asimaki A, Syrris P, Wichter T, Matthias P, Saffitz JE, McKenna WJ. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet . 2007;81(5):964-973. doi:10.1086/521633
  15. Pigors M, Kiritsi D, Krümpelmann S, et al. Lack of plakoglobin leads to lethal congenital epidermolysis bullosa: a novel clinico-genetic entity. Hum Mol Genet . 2011;20(9):1811-1819. doi:10.1093/hmg/ddr064
  16. O’Mahony C, Cauti FM, Pantazis A. The ECG in arrhythmogenic right ventricular cardiomyopathy: ε-waves and anterior T-wave inversion. BMJ Case Rep . 2011;2011:bcr0920103318. Published 2011 May 16. doi:10.1136/bcr.09.2010.3318
  17. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol . 2008;52(25):2175-2187. doi:10.1016/j.jacc.2008.09.019
  18. Corrado D, Zorzi A, Cipriani A, et al. Evolving Diagnostic Criteria for Arrhythmogenic Cardiomyopathy. J Am Heart Assoc . 2021;10(18):e021987. doi:10.1161/JAHA.121.021987
  19. Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria. Int J Cardiol . 2020;319:106-114. doi:10.1016/j.ijcard.2020.06.005
  20. Manole S, Pintican R, Popa G, et al. Diagnostic Challenges in Rare Causes of Arrhythmogenic Cardiomyopathy-The Role of Cardiac MRI. J Pers Med . 2022;12(2):187. Published 2022 Jan 31. doi:10.3390/jpm12020187
  21. te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update. J Cardiovasc Magn Reson . 2014;16(1):50. Published 2014 Jul 20. doi:10.1186/s12968-014-0050-8
  22. Ren J, Chen L, Zhang N, et al. Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy. ESC Heart Fail . 2020;7(4):1547-1559. doi:10.1002/ehf2.12704
  23. Saberniak J, Hasselberg NE, Borgquist R, et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail . 2014;16(12):1337-1344. doi:10.1002/ejhf.181
  24. Gasperetti A, Dello Russo A, Busana M, et al. Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm . 2020;17(8):1251-1259. doi:10.1016/j.hrthm.2020.03.007
  25. Zorzi A, Cipriani A, Bariani R, et al. Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy. Curr Cardiol Rep . 2021 May 7;23(6):57. doi: 10.1007/s11886-021-01489-0.
  26. Kirchhof P, Fabritz L, Zwiener M, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation . 2006;114(17):1799-1806. doi:10.1161/CIRCULATIONAHA.106.624502